Symbols / NKGN $0.06 +0.00% NKGen Biotech, Inc.

Healthcare • Biotechnology • United States • PNK
NKGN Chart
About

NKGen Biotech, Inc., a clinical-stage biotechnology company, develops and commercializes cell therapies for neurodegenerative and oncological diseases based on activated natural killer (NK) cells in the United States. The company develops SNK01, an autologous NK cell therapy candidate in Phase I/IIa trial for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease; and SNK02, which consists of an allogenic NK cell therapy that has completed Phase 1 trial and a HER2-CAR NK cell therapy candidate in pre-clinical trial to treat refractory solid tumors. It has a strategic partnership with HekaBio K.K., a Japan-based healthcare platform, to develop, conduct clinical trials, obtain regulatory approvals, manufacture, and commercialize the company's autologous NK cell therapy product candidates for central nervous system and autoimmune conditions in Japan. The company also has a license agreement with NKMAX Co., Ltd. for the research and development of its NK cell program. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 7.84M
Enterprise Value 46.02M Income -23.55M Sales —
Book/sh -0.98 Cash/sh 6000.00 Dividend Yield —
Payout 0.00% Employees 26 IPO —
P/E — Forward P/E — PEG —
P/S — P/B -0.06 P/C —
EV/EBITDA -2.02 EV/Sales — Quick Ratio 0.00
Current Ratio 0.05 Debt/Eq — LT Debt/Eq —
EPS (ttm) -1.33 EPS next Y — EPS Growth —
Revenue Growth — Earnings — ROA -93.33%
ROE — ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 130.60M
Shs Float 65.51M Short Float 5.53% Short Ratio 0.38
Short Interest — 52W High 0.46 52W Low 0.00
Beta 0.81 Avg Volume 3.08K Volume 200.00
Target Price — Recom None Prev Close $0.06
Price $0.06 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.06
Latest analyst target
3. DCF / Fair value
$-2.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.06
Low
—
High
—
Mean
—
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-05-27 CFIC-2015 NV FAMILY INVESTMENTS LLC., Beneficial Owner of more than 10% of a Class of Security — 19,669,552 $0.28 $5,605,822
2025-05-05 SONG PAUL Y Chief Executive Officer — 20,849,725 $0.13 $2,650,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
-100.00%
0.08
-81.92%
0.43
Operating Revenue
0.00
-100.00%
0.08
-81.92%
0.43
Cost Of Revenue
0.00
-100.00%
0.02
-40.00%
0.03
Reconciled Cost Of Revenue
0.00
-100.00%
0.02
-40.00%
0.03
Gross Profit
0.00
-100.00%
0.06
-85.10%
0.40
Operating Expense
29.75
+21.88%
24.41
+9.65%
22.26
Research And Development
15.67
-6.44%
16.75
+14.14%
14.67
Selling General And Administration
14.08
+83.81%
7.66
+0.98%
7.58
General And Administrative Expense
14.08
+83.81%
7.66
+0.98%
7.58
Other Gand A
14.08
+83.81%
7.66
+0.98%
7.58
Total Expenses
29.75
+21.80%
24.42
+9.58%
22.29
Operating Income
-29.75
-22.18%
-24.35
-11.37%
-21.86
Total Operating Income As Reported
-29.75
-22.18%
-24.35
-11.37%
-21.86
EBITDA
-81.00
-248.67%
-23.23
-12.22%
-20.70
Normalized EBITDA
-52.90
-127.70%
-23.23
-12.22%
-20.70
Reconciled Depreciation
1.20
-0.58%
1.21
-2.73%
1.24
EBIT
-82.20
-236.33%
-24.44
-11.37%
-21.95
Total Unusual Items
-28.10
0.00
—
Total Unusual Items Excluding Goodwill
-28.10
0.00
—
Special Income Charges
-3.33
0.00
—
Restructuring And Mergern Acquisition
3.33
0.00
—
Net Income
-82.95
-210.06%
-26.75
-15.00%
-23.27
Pretax Income
-82.95
-210.12%
-26.75
-14.99%
-23.26
Net Non Operating Interest Income Expense
-25.22
-993.67%
-2.31
-75.36%
-1.31
Interest Expense Non Operating
0.74
-67.69%
2.31
+75.36%
1.31
Net Interest Income
-25.22
-993.67%
-2.31
-75.36%
-1.31
Interest Expense
0.74
-67.69%
2.31
+75.36%
1.31
Other Income Expense
-27.98
-29353.68%
-0.10
-13.10%
-0.08
Other Non Operating Income Expenses
0.12
+226.32%
-0.10
-13.10%
-0.08
Gain On Sale Of Security
-24.77
—
—
Tax Provision
0.01
+0.00%
0.01
+40.00%
0.01
Tax Rate For Calcs
0.00
+0.00%
0.00
-22.22%
0.00
Tax Effect Of Unusual Items
-5.90
0.00
0.00
Net Income Including Noncontrolling Interests
-82.95
-210.06%
-26.75
-15.00%
-23.27
Net Income From Continuing Operation Net Minority Interest
-82.95
-210.06%
-26.75
-15.00%
-23.27
Net Income From Continuing And Discontinued Operation
-82.95
-210.06%
-26.75
-15.00%
-23.27
Net Income Continuous Operations
-82.95
-210.06%
-26.75
-15.00%
-23.27
Normalized Income
-60.75
-127.08%
-26.75
-15.00%
-23.27
Net Income Common Stockholders
-82.95
-210.06%
-26.75
-15.00%
-23.27
Diluted EPS
-5.38
-555.62%
-0.82
-15.00%
-0.71
Basic EPS
-5.38
-555.62%
-0.82
-15.00%
-0.71
Basic Average Shares
15.43
-52.68%
32.60
+0.00%
32.60
Diluted Average Shares
15.43
-52.68%
32.60
+0.00%
32.60
Diluted NI Availto Com Stockholders
-82.95
-210.06%
-26.75
-15.00%
-23.27
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Assets
16.48
+0.92%
16.33
-9.63%
18.07
Current Assets
1.93
+451.43%
0.35
-42.81%
0.61
Cash Cash Equivalents And Short Term Investments
0.03
-77.78%
0.12
-66.67%
0.35
Cash And Cash Equivalents
0.03
-77.78%
0.12
-66.67%
0.35
Receivables
0.03
-72.92%
0.10
+43.28%
0.07
Accounts Receivable
0.00
-100.00%
0.03
0.00
Other Receivables
0.03
-61.19%
0.07
+0.00%
0.07
Prepaid Assets
1.56
+1076.69%
0.13
-22.67%
0.17
Restricted Cash
0.25
0.00
—
Other Current Assets
0.06
+1475.00%
0.00
-81.82%
0.02
Total Non Current Assets
14.55
-8.94%
15.98
-8.47%
17.46
Net PPE
14.46
-8.97%
15.88
-8.56%
17.37
Gross PPE
18.28
-1.56%
18.57
-1.75%
18.90
Accumulated Depreciation
-3.83
-42.19%
-2.69
-75.36%
-1.53
Properties
0.00
0.00
0.00
Land And Improvements
5.03
+0.00%
5.03
+0.00%
5.03
Buildings And Improvements
8.32
+0.00%
8.32
+0.17%
8.31
Machinery Furniture Equipment
0.88
+8.93%
0.81
+0.00%
0.81
Other Properties
4.00
-8.27%
4.37
-7.31%
4.71
Leases
0.05
+0.00%
0.05
+0.00%
0.05
Goodwill And Other Intangible Assets
0.09
-5.15%
0.10
+8.99%
0.09
Other Intangible Assets
0.09
-5.15%
0.10
+8.99%
0.09
Total Liabilities Net Minority Interest
75.17
+409.07%
14.77
-73.69%
56.12
Current Liabilities
39.45
+167.63%
14.74
-73.56%
55.74
Payables And Accrued Expenses
12.69
+437.31%
2.36
-38.34%
3.83
Payables
11.33
+1030.34%
1.00
-72.02%
3.58
Accounts Payable
11.04
+1032.31%
0.97
-43.12%
1.71
Other Payable
0.08
+211.11%
0.03
—
Current Accrued Expenses
1.36
+0.07%
1.36
+447.98%
0.25
Pensionand Other Post Retirement Benefit Plans Current
0.91
+213.06%
0.29
+21.25%
0.24
Current Debt And Capital Lease Obligation
9.99
-16.98%
12.03
-76.68%
51.61
Current Debt
9.99
-14.28%
11.65
-77.22%
51.15
Other Current Borrowings
5.00
-57.10%
11.65
-77.22%
51.15
Current Capital Lease Obligation
0.00
-100.00%
0.38
-17.25%
0.46
Other Current Liabilities
15.86
+28743.64%
0.06
-12.70%
0.06
Total Non Current Liabilities Net Minority Interest
35.72
+137292.31%
0.03
-93.14%
0.38
Long Term Debt And Capital Lease Obligation
9.93
0.00
-100.00%
0.36
Long Term Debt
9.93
—
—
Long Term Capital Lease Obligation
—
0.00
-100.00%
0.36
Non Current Deferred Liabilities
0.03
+26.92%
0.03
+36.84%
0.02
Non Current Deferred Taxes Liabilities
0.03
+26.92%
0.03
+36.84%
0.02
Stockholders Equity
-58.69
-3855.15%
1.56
+104.11%
-38.05
Common Stock Equity
-58.69
-3855.15%
1.56
+104.11%
-38.05
Capital Stock
0.00
+100.00%
0.00
-92.86%
0.01
Common Stock
0.00
+100.00%
0.00
-92.86%
0.01
Share Issued
21.89
+0.00%
21.89
+0.00%
21.89
Ordinary Shares Number
21.89
+0.00%
21.89
+0.00%
21.89
Additional Paid In Capital
121.73
+50.77%
80.74
+462.40%
14.36
Retained Earnings
-162.13
-104.77%
-79.18
-51.04%
-52.42
Total Equity Gross Minority Interest
-58.69
-3855.15%
1.56
+104.11%
-38.05
Total Capitalization
-48.76
-3219.83%
1.56
+104.11%
-38.05
Working Capital
-37.52
-160.73%
-14.39
+73.90%
-55.13
Invested Capital
-38.77
-393.33%
13.22
+0.89%
13.10
Total Debt
19.92
+65.54%
12.03
-76.84%
51.97
Net Debt
19.89
+72.43%
11.54
-77.29%
50.80
Capital Lease Obligations
0.00
-100.00%
0.38
-53.67%
0.82
Net Tangible Assets
-58.78
-4109.89%
1.47
+103.84%
-38.14
Tangible Book Value
-58.78
-4109.89%
1.47
+103.84%
-38.14
Derivative Product Liabilities
25.76
0.00
—
Dueto Related Parties Current
0.20
0.00
-100.00%
1.87
Line Of Credit
4.99
0.00
—
Other Equity Interest
-18.29
—
—
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-21.95
+2.70%
-22.56
-15.39%
-19.55
Cash Flow From Continuing Operating Activities
-21.95
+2.70%
-22.56
-15.39%
-19.55
Net Income From Continuing Operations
-82.95
-210.06%
-26.75
-15.00%
-23.27
Depreciation Amortization Depletion
1.20
-0.58%
1.21
-2.73%
1.24
Depreciation
—
1.65
+32.64%
1.24
Depreciation And Amortization
1.20
-0.58%
1.21
-2.73%
1.24
Other Non Cash Items
4.20
+54.74%
2.71
+107.74%
1.30
Stock Based Compensation
4.13
+5892.75%
0.07
-25.81%
0.09
Operating Gains Losses
24.92
—
—
Gain Loss On Investment Securities
24.92
—
—
Unrealized Gain Loss On Investment Securities
24.33
+13645.76%
0.18
+23.78%
0.14
Change In Working Capital
2.23
+7320.00%
0.03
-96.78%
0.93
Change In Receivables
0.03
+200.00%
-0.03
-126.13%
0.11
Changes In Account Receivables
0.03
+200.00%
-0.03
-126.13%
0.11
Change In Prepaid Assets
-1.40
-2561.40%
0.06
+218.75%
-0.05
Change In Payables And Accrued Expense
3.99
+801.35%
0.44
-53.81%
0.96
Change In Other Working Capital
-0.01
-250.00%
-0.00
-115.38%
0.03
Change In Other Current Liabilities
-0.38
+13.27%
-0.44
-276.72%
-0.12
Investing Cash Flow
-0.05
+70.55%
-0.16
+64.49%
-0.46
Cash Flow From Continuing Investing Activities
-0.05
+70.55%
-0.16
+64.49%
-0.46
Net PPE Purchase And Sale
0.00
+100.00%
-0.10
+74.94%
-0.40
Purchase Of PPE
0.00
+100.00%
-0.10
+74.94%
-0.40
Capital Expenditure
-0.05
+70.55%
-0.16
+64.49%
-0.46
Capital Expenditure Reported
-0.05
+22.58%
-0.06
-10.71%
-0.06
Financing Cash Flow
22.16
-1.47%
22.49
+11.54%
20.16
Cash Flow From Continuing Financing Activities
22.16
-1.47%
22.49
+11.54%
20.16
Net Issuance Payments Of Debt
26.21
+17.38%
22.32
+11.09%
20.10
Issuance Of Debt
26.51
+15.24%
23.00
+12.20%
20.50
Repayment Of Debt
-0.30
+55.56%
-0.68
-67.08%
-0.40
Long Term Debt Issuance
16.21
0.00
—
Long Term Debt Payments
0.00
+100.00%
-0.68
-67.08%
-0.40
Net Long Term Debt Issuance
16.21
+2502.22%
-0.68
-67.08%
-0.40
Short Term Debt Issuance
10.29
-55.26%
23.00
+12.20%
20.50
Short Term Debt Payments
-0.30
0.00
+100.00%
-0.40
Net Short Term Debt Issuance
9.99
-56.56%
23.00
+12.20%
20.50
Net Common Stock Issuance
1.67
0.00
-100.00%
0.06
Proceeds From Stock Option Exercised
10.22
+6249.07%
0.16
+155.56%
0.06
Net Other Financing Charges
-15.94
—
—
Changes In Cash
0.16
+167.95%
-0.23
-253.95%
0.15
Beginning Cash Position
0.12
-66.67%
0.35
+76.38%
0.20
End Cash Position
0.28
+135.90%
0.12
-66.67%
0.35
Free Cash Flow
-22.00
+3.19%
-22.72
-13.56%
-20.01
Interest Paid Supplemental Data
0.24
+588.57%
0.04
—
Common Stock Issuance
1.67
0.00
-100.00%
0.06
Issuance Of Capital Stock
1.67
0.00
-100.00%
0.06
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category